What is the first-line antibiotic for a cirrhotic patient with suspected variceal bleeding presenting with hematemesis?

Antibiotic of Choice for Hematemesis in Cirrhotic Patients

Ceftriaxone 1 g IV every 24 hours is the first-line antibiotic for cirrhotic patients with suspected variceal bleeding presenting with hematemesis, particularly in those with decompensated cirrhosis (Child-Pugh B or C), those already on quinolone prophylaxis, or in settings with high quinolone resistance. 1

Primary Recommendation

• Initiate ceftriaxone 1 g IV every 24 hours immediately upon presentation with suspected variceal bleeding, before endoscopy is performed 1, 2
• Continue antibiotic prophylaxis for up to 7 days maximum 1
• Start antibiotics simultaneously with vasoactive agents (terlipressin, octreotide, or somatostatin) as soon as variceal bleeding is suspected 1, 2

Alternative Antibiotic Option

• Oral norfloxacin 400 mg twice daily can be used in patients with compensated cirrhosis (Child-Pugh A) who are not already on quinolone prophylaxis and in settings with low quinolone resistance 1
• IV ciprofloxacin is an alternative when oral administration is not possible 1

Rationale for Ceftriaxone as First Choice

The 2018 EASL guidelines explicitly state that ceftriaxone is superior to quinolones in specific populations. 1 A key randomized trial comparing ceftriaxone to norfloxacin demonstrated significantly lower infection rates with ceftriaxone (11% vs 33%, p=0.003), including lower rates of spontaneous bacterial peritonitis and bacteremia (2% vs 12%, p=0.03). 1 This difference was largely explained by quinolone-resistant organisms in patients receiving norfloxacin. 1

Evidence for Antibiotic Prophylaxis

• Antibiotic prophylaxis reduces mortality, infection rates, and rebleeding in cirrhotic patients with GI bleeding 1
• Meta-analyses show prophylactic antibiotics decrease bleeding-related mortality (RR 0.79), bacterial infections (RR 0.35), and rebleeding (RR 0.53) 1
• Bacterial infection is an independent predictor of failure to control bleeding and death 1

Clinical Algorithm for Antibiotic Selection

Use Ceftriaxone 1 g IV daily if ANY of the following:

• Advanced/decompensated cirrhosis (Child-Pugh B or C) 1
• Patient already on quinolone prophylaxis 1
• Hospital setting with high prevalence of quinolone-resistant organisms 1
• Inability to take oral medications 1

Use Norfloxacin 400 mg PO twice daily if ALL of the following:

• Compensated cirrhosis (Child-Pugh A) 1
• NOT on quinolone prophylaxis 1
• Low local quinolone resistance 1
• Able to take oral medications 1

Important Caveats

• Local antimicrobial resistance patterns should guide final antibiotic selection 1
• Recent evidence questions the mortality benefit of antibiotic prophylaxis in the modern era, though infection reduction remains significant 3
• However, all major international guidelines (EASL, AASLD, APASL, KASL, ESGE) unanimously recommend antibiotic prophylaxis as standard of care 1, 2
• Norfloxacin is no longer available in the United States, making ceftriaxone the practical choice in most U.S. centers 1

Duration and Monitoring

• Maximum duration is 7 days 1
• Antibiotic prophylaxis should be initiated on presentation and continued regardless of endoscopic findings 1
• Treatment applies to both variceal and non-variceal sources of GI bleeding in cirrhotic patients 1